Javier Villanueva-Meyer

University Of California, San Francisco

$1,315,707

Attributed

$3,725,057

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY2021–25

$2M$1.5M$1M$500K$0

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$3,725,057 · 2

By mechanism

R01$3,280,932 · 1

R21$444,125 · 1

Top collaborators

Most similar at University Of California, San Francisco

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Lesion”

Paula Gonzalez-Maya · Fundacion Inciensa$17,061,460
Rachana Agarwal · Leidos Biomedical Research, Inc.$15,241,462
Thomas Dick · Rbhs-New Jersey Medical School$10,715,746
J. Silvio Gutkind · University Of California, San Diego$8,475,093
Gabriel Nestor Sanchez · Enspectra Health, Inc.$7,941,485
Vikram Khurana · Brigham And Women'S Hospital$6,679,723

Research focus

LesionMagnetic Resonance ImagingMetabolismTumorProtonsMutationImageMetabolicProtocols DocumentationTissuesEvaluationBrainDiagnosisPositioning AttributeFirst-In-HumanGliomaTechnologyCarbonBrain NeoplasmsEffective TherapyBrain AbnormalitiesAstrocytomaEdemaBlood Volume

Grant awards (6)

Multimodality Neuroimaging Evaluation of Cognitive Functioning in Lower Grade Astrocytoma$1,334,513

R01 · FY2025 · CA

Multimodality Neuroimaging Evaluation of Cognitive Functioning in Lower Grade Astrocytoma$633,896

R01 · FY2024 · CA

Multimodality Neuroimaging Evaluation of Cognitive Functioning in Lower Grade Astrocytoma$653,911

R01 · FY2023 · CA

Multimodality Neuroimaging Evaluation of Cognitive Functioning in Lower Grade Astrocytoma$658,612

R01 · FY2022 · CA

Diagnosis of low-grade glial tumors using 11C glutamine isotopomers$242,250

R21 · FY2022 · EB · contact PI

Diagnosis of low-grade glial tumors using 11C glutamine isotopomers$201,875

R21 · FY2021 · EB · contact PI